Researchers at EPFL have developed remote-controlled, mechanical microdevices that, when inserted into human tissue, can manipulate the fluid that surrounds them, collect cells or release drugs. This breakthrough offers numerous potential applications in the biomedical field, from diagnostics to therapy.
Does the idea of a soft, cell-sized capsule that can be injected into your body in order to collect samples for biopsy, release medication or carry out targeted interventions seem unimaginable? It wasn’t for the scientists in EPFL’s MicroBioRobotic Systems Laboratory (MICROBS), who have come up with technology that does all of these things. “The core component of our device is an acoustic microengine, which we manufactured using 3D nanoprinting,” says Selman Sakar, a professor at the Institute of Mechanical Engineering. “The parts are made out of hydrogel, a biocompatible material that is about as stiff as human tissue. We then drew on computational simulations to invent a complex microdevice consisting of several engines.”
“After the device enters the body, it has to be actuated remotely,” says Sakar. “It would be too invasive to use tethers such as cables or tubes.” The researchers use ultrasound to actuate the specific microengines and manipulate the surrounding fluid. “The device works precisely because of its structural design. Using mechanical resonance, we can carefully control which part of the device is actuated by modulating the frequency of acoustic excitation.”
Sakar’s team has also developed an array of engines and mechanisms. By combining various parts – pumps, a collection chamber and filters of various sizes – they designed a biopsy device. The researchers have also built mobile devices that are propelled by the fluid flow generated by acoustic microengines.
Programmable in vivo pharmacology and targeted therapy
Combining this technology with medical imaging means patients will be able to undergo long-term monitoring without any outside intervention. “We have freed microfluidics technology from its electronic and external constraints,” says Murat Kaynak, lead author of the study. “Microfluidic devices can now be injected into human tissue and used to greatly enhance biochemical analysis thanks to the tunability of hydrogels.”
The devices could also be used for therapeutic purposes. “Doctors will be able to program the device to release a specific drug dosage when actuated by ultrasound,” adds Kaynak. “This will allow them to treat a specific part of the body and minimize the side effects.”
While injecting the microscopic devices is minimally invasive, removing the devices has proven more of a challenge. The solution can be found in the materials used to construct the device. “How long a device lasts depends on the materials it’s made of,” says Kaynak. “Some hydrogels biodegrade quickly while others stick around longer. The actuation concept works well with various types of polymers.”
Only in vitro experiments have been conducted so far. The next step will be to test these devices in vivo.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Bisu Raises $3.2M in Seed Funding
Bisu, a Tokyo, Japan-based health tech startup, raised $3.2M in Seed funding. The round was led by QUAD, with participation from ASICS Ventures Corporation, 15 th Rock Ventures, Pacifico Investments ...
- Global Microfluidic Device System Market 2021-2027 in Covid-19 100% Accurate Analysis of Company Stocks and Strategic Development
Global Microfluidic Device System Market Report Covers Industrial Analysis, Market Growth Stimulators, And Future Scope. Global Microfluidic Device System market report penciled d ...
- uFluidix Expands Their Portfolio of Coatings for Microfluidics to Meet Increasing Demand
Microfluidics technology is a vital component of diagnostic testing and microfluidics manufacturer, uFluidix, is at the forefront of the industry. Following a major expansion in 2020 which saw the ...
- The global microfluidics market is projected to reach USD 58.8 billion by 2026 from USD 20.7 billion in 2021, growing at a CAGR of 23.2%
Microfluidic technologies offer quick analysis, reduced reagent consumption, and accurate test results and help in reducing the overall cost of the drug development process.New York, Oct. 04, 2021 ...
- Could BYU-developed lab-on-a-chip devices help save lives?
An interdisciplinary team of researchers at BYU has developed a new 3D printing technique to create the smallest ever, high resolution microfluidic lab-on-a-chip devices.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Global Power Float (Ride-on (Hydrostatic, Mechanical), Walk Behind) Markets, Competition Forecast & Opportunities, 2027 - ResearchAndMarkets.com
DUBLIN, October 08, 2021--(BUSINESS WIRE)--The "Global Power Float Market, By Type (Ride-on (Hydrostatic, Mechanical), Walk Behind), By Application (Commercial ...
- Russian physicists put forward new way to calculate fluctuation forces
They arise from a vacuum and appear due to very small quantum-mechanical deviations (fluctuations ... can be useful for developing various microdevices, for example, for biomedical purposes.
- MEMS' Fantastic Voyages
Additionally, he says, because mechanical MEMS devices live in an electrical world ... For a long time, says Microfabrica Inc. Applications Engineering Director Nelsimar Vandelli, micro devices could ...
- Generational Equity Advises Page Mechanical Group in its Sale to Reedy Industries
The acquisition closed August 23, 2021. Page Mechanical Group, (PMG), is the leading commercial HVAC contractor serving Southwest Florida with locations in Tampa, Fort Myers, and West Palm Beach.
- Buy The Dip Or Mechanical Rip? Why The Market Is Surging
Mott Capital Management writes short-to-medium-term focused articles on where stocks may go. We do not write articles on investing for the long-term. In a typical article, we will tell readers ...